Supplementary Figure S1 from Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate Cancer

2026 Open access

Read full text
Authors: Fatima Alhourani, Marine Tauziet, Margaux Ayeul, Pierre Dambrun, Hiba Daher, Julie Patouillard, Benoît Miotto, Aurélie Gennetier, Simon George, Xavier Mialhe, Mona Dergham, Florence M. Cammas
+8 more Adeline Torro, Diego Tosi, Céline Gongora, Philippe Pourquier, Cyril Ribeyre, Véronique Baldin, Raghida Abou Merhi, Eric Julien
DOI: 10.1158/0008-5472.30986385
Cited by: 0

Abstract

Figure S1 shows SUV4-20H2 expression across Gleason scores, prostate cancer patient categories, TP53 mutation status, ERG structural variants, two neoplasm disease lymph node stages, and with or without SPOP mutations and TMPRSS2 structural variants.

Fields of Study & Subjects

Cancer therapeutics and mechanisms Prostate Cancer Treatment and Research Chemical Reactions and Isotopes

Publication details

Publication date
2 January 2026